Poi, Ming J <br/><br/>
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.  [electronic resource] 

 -  Clinical pharmacokinetics  Aug 2013 
 - 705-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.1007/s40262-013-0064-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Deaminase Inhibitors--administration & dosage<br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Area Under Curve<br/>Blood Transfusion, Autologous<br/>Creatinine--blood<br/>Cyclosporine--administration & dosage<br/>Drug Resistance<br/>Female<br/>Graft vs Host Disease--blood<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Infliximab<br/>Lymphocyte Transfusion<br/>Male<br/>Methotrexate--administration & dosage<br/>Methylprednisolone--therapeutic use<br/>Middle Aged<br/>Pentostatin--administration & dosage<br/>Renal Insufficiency--blood<br/>Stem Cell Transplantation<br/>Tacrolimus--administration & dosage<br/>Young Adult